Holen Sie sich die Stockscreener-App
7.29
0.00%
0.00
Handel nachbörslich:
7.58
0.29
+3.98%
Schlusskurs vom Vortag:
$7.29
Offen:
$7.2
24-Stunden-Volumen:
14,702
Relative Volume:
0.67
Marktkapitalisierung:
$6.72M
Einnahmen:
$4.03M
Nettoeinkommen (Verlust:
$24.32M
KGV:
-1.695
EPS:
-4.3008
Netto-Cashflow:
$-45.76M
1W Leistung:
-0.55%
1M Leistung:
-33.97%
6M Leistung:
-59.41%
1J Leistung:
-60.77%
1-Tages-Spanne:
$7.10
$7.58
1-Wochen-Bereich:
$6.26
$9.255
52-Wochen-Spanne:
$6.00
$26.85
Pavmed Inc Stock (PAVM) Company Profile
Firmenname
Pavmed Inc
Sektor
Branche
Telefon
(212) 949-4319
Adresse
360 MADISON AVENUE, NEW YORK, NY
Vergleichen Sie PAVM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
7.29 | 6.72M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-05 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2018-06-28 | Eingeleitet | Maxim Group | Buy |
Pavmed Inc Aktie (PAVM) Neueste Nachrichten
Is PAVmed Inc. stock a top momentum playJuly 2025 Levels & Reliable Intraday Trade Plans - ulpravda.ru
Can PAVmed Inc. stock deliver consistent earnings growthWeekly Stock Summary & Daily Stock Trend Watchlist - ulpravda.ru
PAVmed (PAVM) price target decreased by 12.50% to 10.71 - MSN
PAVmed approves reverse stock split amendment - MSN
PAVmed trading halted, news pending - MSN
PAVmed Inc.: Shareholders Board Members Managers and Company Profile | US70387R5028 - MarketScreener
PAVmed Announces Reverse Stock Split - citybiz
PAVmed’s Earnings Call: Triumphs and Trials - MSN
PAVmed, Inc. Financial Disclosures & Filings - TradingView — Track All Markets
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - MarketScreener
PAVMED announces 1-for-30 reverse stock split - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
PAVmed stock drops after announcing 1-for-30 reverse split By Investing.com - Investing.com Canada
PAVmed (PAVM) Announces 1-for-30 Reverse Stock Split - GuruFocus
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
PAVmed to implement 1-for-30 reverse stock split in January - Investing.com Nigeria
PAVmed stock drops after announcing 1-for-30 reverse split - Investing.com India
PAVmed to implement 1-for-30 reverse stock split in January By Investing.com - Investing.com South Africa
PAVmed Announces Reverse Stock Split to Maintain Nasdaq Listing - TipRanks
PAVmed announces reverse stock split - marketscreener.com
Why this medical tech company is shrinking its stock 1-for-30 next week - Stock Titan
PAVmed Inc. (NASDAQ:PAVM) Sees Large Drop in Short Interest - Defense World
PAVmed Inc (PAVMZ) Fundamental Analysis - Meyka
Here's Why Lucid Diagnostics (LUCD) Declined in Q3 - Finviz
Is PAVmed Inc. stock a buy on dips2025 Technical Overview & Free Fast Gain Swing Trade Alerts - Улправда
Nasdaq Moves: Will PAVmed Inc. stock gain from strong economyEarnings Trend Report & Reliable Price Breakout Alerts - Улправда
Will PAVmed Inc. stock gain from strong economy2025 Price Momentum & Free Low Drawdown Momentum Trade Ideas - Улправда
PAVM FinancialsIncome Statement - Quiver Quantitative
Ascendiant Capital Maintains PAVmed (PAVM) Buy Recommendation - Nasdaq
Ascendiant Capital Lowers Price Target for PAVmed (PAVM) to $17. - GuruFocus
PAVmed stock price target lowered to $17 from $20 at Ascendiant Capital By Investing.com - Investing.com South Africa
PAVmed stock price target lowered to $17 from $20 at Ascendiant Capital - Investing.com
Lucid Diagnostics reports real-world data on esophageal test device By Investing.com - Investing.com Australia
Lucid Diagnostics reports real-world data on esophageal test device - Investing.com
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection - PR Newswire
PAVmed Approves Reverse Stock Split Amendment - The Globe and Mail
Lucid Diagnostics Announces $15.3 Million Registered Direct Offe - GuruFocus
Can PAVmed Inc. stock rebound after recent weaknessMarket Growth Report & Daily Market Momentum Tracking - Newser
Is PAVmed Inc. stock cheap compared to fundamentals2025 Short Interest & Capital Efficiency Focused Ideas - Newser
PAVmed (PAVM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
What drives PAVmed Inc stock priceInflation Impact on Stocks & Control Your Emotions With Discipline Tools - earlytimes.in
Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest shareholders are individual investors with 38% ownership, public companies own 30% - Yahoo Finance Singapore
Risk Check: Will PAVmed Inc. stock gain from strong economyRecession Risk & Advanced Swing Trade Entry Plans - BỘ NỘI VỤ
Why Being Public Gave PavMed a Competitive Edge - Medical Device and Diagnostic industry
What analysts say about PAVmed Inc stockPrice Channel Trading & Small Investment Capital Tips - earlytimes.in
Pavmed Inc. Reports Q3 2025 Earnings and Strategic Focus - MSN
Will PAVmed Inc. stock benefit from upcoming earnings reports2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
Finanzdaten der Pavmed Inc-Aktie (PAVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):